Your Basket is currently empty

Your Bookshelf is empty!

Your Basket is currently empty


Banner

Pharmaceutical and Medical Device Safety

A Study in Public and Private Regulation

By: Sonia Macleod, Sweta Chakraborty
Media of Pharmaceutical and Medical Device Safety
See larger image
Published: 21-02-2019
Format: Hardback
Edition: 1st
Extent: 208
ISBN: 9781509916696
Imprint: Hart/Beck
Series: Civil Justice Systems
Dimensions: 244 x 169 mm
RRP : £55.00
 

: (?)

Buying pre-order items

Your pre-order item will usually be shipped on the publishing date of the book.

Ebooks

You will receive an email with a download link for the ebook on the publication date.

Payment

You will not be charged for pre-ordered books until they are available to be shipped. Pre-ordered ebooks will not be charged for until they are available for download.

Amending or cancelling your order

For orders that have not been shipped you can usually make changes to pre-orders up to 24 hours before the publishing date.

This book is also available in other formats: View formats

Delivery & Returns

Tell others about this product

Loren Epson

About Pharmaceutical and Medical Device Safety

This book examines how regulatory and liability mechanisms have impacted upon product safety decisions in the pharmaceutical and medical devices sectors in Europe, the USA and beyond since the 1950s. Thirty-five case studies illustrate the interplay between the regulatory regimes and litigation. Observations from medical practice have been the overwhelming means of identifying post-marketing safety issues. Drug and device safety decisions have increasingly been taken by public regulators and companies within the framework of the comprehensive regulatory structure that has developed since the 1960s. In general product liability cases have not identified or defined safety issues, and function merely as compensation mechanisms. This is unsurprising as the thresholds for these two systems differ considerably; regulatory action can be triggered by the possibility a product is harmful, whereas establishing liability in litigation requires proving that the product was actually harmful.

As litigation normally post-dates regulatory implementation, the 'private enforcement' of public law has generally not occurred in these sectors. This has profound implications for the design of sectoral regulatory and liability regimes, including associated features such as extended liability law, class actions and contingency fees. This book forms a major contribution to the academic debate on the comparative utility of regulatory and liability systems, on public versus private enforcement, and on mechanisms of behaviour control.

Bookmark and Share

Sky News Interview with Sweta Chakraborty

Close